BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22629364)

  • 1. Antimalarial iron chelator, FBS0701, shows asexual and gametocyte Plasmodium falciparum activity and single oral dose cure in a murine malaria model.
    Ferrer P; Tripathi AK; Clark MA; Hand CC; Rienhoff HY; Sullivan DJ
    PLoS One; 2012; 7(5):e37171. PubMed ID: 22629364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimalarial iron chelator FBS0701 blocks transmission by Plasmodium falciparum gametocyte activation inhibition.
    Ferrer P; Vega-Rodriguez J; Tripathi AK; Jacobs-Lorena M; Sullivan DJ
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1418-26. PubMed ID: 25512427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase 1 dose-escalation study: safety, tolerability, and pharmacokinetics of FBS0701, a novel oral iron chelator for the treatment of transfusional iron overload.
    Rienhoff HY; Viprakasit V; Tay L; Harmatz P; Vichinsky E; Chirnomas D; Kwiatkowski JL; Tapper A; Kramer W; Porter JB; Neufeld EJ
    Haematologica; 2011 Apr; 96(4):521-5. PubMed ID: 21173101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload.
    Neufeld EJ; Galanello R; Viprakasit V; Aydinok Y; Piga A; Harmatz P; Forni GL; Shah FT; Grace RF; Porter JB; Wood JC; Peppe J; Jones A; Rienhoff HY
    Blood; 2012 Apr; 119(14):3263-8. PubMed ID: 22251482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmodium falciparum and Plasmodium yoelii: effect of the iron chelation prodrug dexrazoxane on in vitro cultures.
    Loyevsky M; Sacci JB; Boehme P; Weglicki W; John C; Gordeuk VR
    Exp Parasitol; 1999 Feb; 91(2):105-14. PubMed ID: 9990337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron chelators: in vitro inhibitory effect on the liver stage of rodent and human malaria.
    Stahel E; Mazier D; Guillouzo A; Miltgen F; Landau I; Mellouk S; Beaudoin RL; Langlois P; Gentilini M
    Am J Trop Med Hyg; 1988 Sep; 39(3):236-40. PubMed ID: 3052118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the effect of the oral iron chelator deferiprone on asymptomatic Plasmodium falciparum parasitemia in humans.
    Thuma PE; Olivieri NF; Mabeza GF; Biemba G; Parry D; Zulu S; Fassos FF; McClelland RA; Koren G; Brittenham GM; Gordeuk VR
    Am J Trop Med Hyg; 1998 Mar; 58(3):358-64. PubMed ID: 9546419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combined effect of iron chelators and classical antimalarials on the in-vitro growth of Plasmodium falciparum.
    van Zyl RL; Havlik I; Monteagudo FS
    J Antimicrob Chemother; 1992 Sep; 30(3):273-8. PubMed ID: 1452491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine.
    Alin MH; Kihamia CM; Bjorkman A; Bwijo BA; Premji Z; Mtey GJ; Ashton M
    Am J Trop Med Hyg; 1995 Dec; 53(6):639-45. PubMed ID: 8561267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying a Deferiprone-Resveratrol Hybrid as an Effective Lipophilic Anti-Plasmodial Agent.
    Maneekesorn S; Chuljerm H; Koonyosying P; Uthaipibull C; Ma Y; Srichairatanakool S
    Molecules; 2021 Jul; 26(13):. PubMed ID: 34279413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antimalarial effect of iron chelators: studies in animal models and in humans with mild falciparum malaria.
    Hershko C; Gordeuk VR; Thuma PE; Theanacho EN; Spira DT; Hider RC; Peto TE; Brittenham GM
    J Inorg Biochem; 1992 Aug 15-Sep; 47(3-4):267-77. PubMed ID: 1431886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimalarial effect of iron chelators.
    Gordeuk VR; Loyevsky M
    Adv Exp Med Biol; 2002; 509():251-72. PubMed ID: 12572998
    [No Abstract]   [Full Text] [Related]  

  • 13. DSM265 at 400 Milligrams Clears Asexual Stage Parasites but Not Mature Gametocytes from the Blood of Healthy Subjects Experimentally Infected with
    Collins KA; Rückle T; Elliott S; Marquart L; Ballard E; Chalon S; Griffin P; Möhrle JJ; McCarthy JS
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30858218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deferiprone (L1) as an adjuvant therapy for Plasmodium falciparum malaria.
    Mohanty D; Ghosh K; Pathare AV; Karnad D
    Indian J Med Res; 2002 Jan; 115():17-21. PubMed ID: 12424933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primaquine for reducing Plasmodium falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008152. PubMed ID: 22972117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Single-Dose Combination Study with the Experimental Antimalarials Artefenomel and DSM265 To Determine Safety and Antimalarial Activity against Blood-Stage Plasmodium falciparum in Healthy Volunteers.
    McCarthy JS; Rückle T; Elliott SL; Ballard E; Collins KA; Marquart L; Griffin P; Chalon S; Möhrle JJ
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31685476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial.
    Gaur AH; McCarthy JS; Panetta JC; Dallas RH; Woodford J; Tang L; Smith AM; Stewart TB; Branum KC; Freeman BB; Patel ND; John E; Chalon S; Ost S; Heine RN; Richardson JL; Christensen R; Flynn PM; Van Gessel Y; Mitasev B; Möhrle JJ; Gusovsky F; Bebrevska L; Guy RK
    Lancet Infect Dis; 2020 Aug; 20(8):964-975. PubMed ID: 32275867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo reversal of chloroquine resistance in Plasmodium falciparum with promethazine.
    Oduola AM; Sowunmi A; Milhous WK; Brewer TG; Kyle DE; Gerena L; Rossan RN; Salako LA; Schuster BG
    Am J Trop Med Hyg; 1998 May; 58(5):625-9. PubMed ID: 9598452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of N-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelators.
    Hershko C; Theanacho EN; Spira DT; Peter HH; Dobbin P; Hider RC
    Blood; 1991 Feb; 77(3):637-43. PubMed ID: 1991172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of Plasmodium falciparum parasitemia regarding combined treatment regimens for acute uncomplicated malaria, Antioquia, Colombia.
    Alvarez G; Tobón A; Piñeros JG; Ríos A; Blair S
    Am J Trop Med Hyg; 2010 Jul; 83(1):90-6. PubMed ID: 20595483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.